Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 11, 2026
Why Is AeroVironment, Inc. (AVAV) Stock Down -6% Today?

Why Is AeroVironment, Inc. (AVAV) Stock Down -6% Today?

Key Takeaways

  • AVAV shares are declining approximately 6% in Monday's session, trading near $158.19, compared to Friday's close of $168.29
  • Continued selling pressure stems from lingering overhang tied to a significant Q3 FY2026 earnings and revenue miss reported in March 2026, compounded by a full-year guidance cut
  • The termination of AeroVironment's approximately $1.4 billion SCAR Space Force contract — which was reopened for competitive bidding in early 2026 — remains a structural headwind for the stock
  • A Pomerantz Law Firm investor investigation announced in the wake of the guidance cut adds legal overhang and amplifies institutional caution
  • Defense sector sentiment has turned more cautious amid shifting government spending priorities and Pentagon budget scrutiny in 2026
  • Traders are watching for Q4 FY2026 earnings, expected in late June or early July 2026, which management has framed as a potential record quarter

Opening Summary

AeroVironment, Inc. (AVAV) is a Huntsville, Alabama-based defense technology company specializing in small unmanned aircraft systems (UAS), loitering munitions, and precision strike solutions, as well as space, cyber, and directed energy products. The company serves the U.S. military and international defense customers, with its Switchblade loitering munitions and Puma UAS among its most recognized platforms. AVAV shares are declining approximately 6% in Monday's session, trading near $158.19 against a Friday close of $168.29, as a combination of unresolved fundamental concerns, contract uncertainty, and a cautious defense sector backdrop weigh on investor sentiment.

Q3 FY2026 Earnings Miss and Guidance Cut

The primary fundamental driver pressing AVAV lower over recent sessions has been the company's Q3 FY2026 results, released on March 10, 2026, which significantly missed expectations. Revenue came in at $408.1 million, well short of the analyst consensus of approximately $487.9 million — a miss of roughly 16%. Non-GAAP EPS of $0.64 missed the consensus estimate of $0.72 by $0.08. More impactful than the quarterly miss was management's decision to cut full-year FY2026 guidance, reducing the revenue outlook to $1.85–$1.95 billion (from $1.9–$2.0 billion) and non-GAAP EPS guidance to $2.75–$3.10 against a prior Street consensus of $3.28–$3.31. Management attributed the shortfall to timing of revenue recognition and funding delays in its Space, Cyber, and Directed Energy (SCDE) segment. The stock fell sharply on the news and has remained under pressure, with the May 11 session extending those losses.

SCAR Contract Termination Removes a Pillar of the Thesis

A significant structural concern for AVAV has been the loss of its SCAR (Space and Cyberspace Advanced Reconnaissance) Space Force contract, valued at approximately $1.4 billion and representing a core part of the SCDE segment's revenue pipeline. Earlier in 2026, the Pentagon announced it would reopen the program to competitive bidding rather than maintain sole-source status with AeroVironment. Raymond James responded by issuing a rare triple downgrade on AVAV, cutting its rating from Strong Buy to Underperform in a single action. The potential loss of this contract, which had underpinned bullish forecasts for the SCDE division, remains unresolved and continues to create uncertainty around the company's long-term revenue base.

Legal Overhang and Broader Sentiment Headwinds

Investor class-action interest has added a further layer of caution around AVAV. Following the Q3 guidance reduction, Pomerantz LLP announced an investigation into whether the company or its officers engaged in securities fraud or other unlawful conduct. While no formal lawsuit has been filed, this type of legal overhang has historically amplified institutional selling and increases short-term volatility. At the same time, the broader defense sector has faced scrutiny in 2026 as Pentagon budget discussions and DOGE-related government spending reviews have raised questions about the durability of near-term DoD procurement contracts for smaller, specialized defense technology firms.

Market Context and Trading Activity

Monday's session volume for AVAV is running below the 90-day average of approximately 1.5 million shares per day, suggesting the move reflects repositioning rather than a high-conviction surge of new selling. The broader Nasdaq has been trading with moderate positive momentum entering the week, meaning AVAV's decline is diverging from index performance and remains stock-specific. From a technical perspective, the stock has fallen approximately 60% from its 52-week high of around $417, with support levels in the $155–$160 range now being tested. A decisive break below this zone could invite additional selling pressure, while a stabilization here may attract value-oriented buyers ahead of the Q4 earnings release.

Trending AI Robots

For traders watching volatile defense and technology stocks like AVAV, Tickeron's Trending AI Robots page offers a curated look at the platform's best-performing automated trading strategies under current market conditions. Tickeron runs hundreds of AI-powered bots spanning thousands of tickers, each built with distinct strategies, timeframes, performance metrics, and traded symbols — but only those delivering the strongest real-time results appear in the Trending section. Whether you trade momentum, mean reversion, or sector-specific setups, the Trending AI Robots page provides a data-driven filter for identifying systematic strategies aligned with today's market dynamics.

What Comes Next for AVAV

The most anticipated near-term catalyst for AVAV is the Q4 FY2026 earnings report, expected in late June or early July 2026, covering the fiscal quarter ending April 30, 2026. Management guided for a record Q4, with significantly higher revenue and margins compared to the prior quarter, citing strong backlog visibility and anticipated recognition of delayed SCDE revenues. The company reported a book-to-bill ratio of 1.60x as of Q3, with total funded backlog of $1.1 billion and unfunded backlog of $3.0 billion — figures that support the bull case if execution improves. Key risks include further funding delays within the DoD, adverse outcomes on the SCAR competitive rebid, continued margin compression in the Autonomous Systems division, and unresolved legal developments. Analyst price targets as of the most recent updates range from $200 to $390, reflecting wide dispersion in how the Street is pricing execution risk versus the company's long-term UAS and directed-energy growth runway.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: AVAV

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AVAV's Stochastic Oscillator is remaining in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for AVAV crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAV advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 225 cases where AVAV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AVAV moved out of overbought territory on August 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVAV as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVAV turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

AVAV moved below its 50-day moving average on August 20, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVAV broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AVAV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.850) is normal, around the industry mean (7.037). P/E Ratio (149.026) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (3.978) is also within normal values, averaging (20.174).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVAV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
AVAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of unmanned aircraft and charging systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
241 18th Street South
Phone
+1 703 418-2828
Employees
3731
Web
https://www.avinc.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.